EDITORIAL
Published on 07 Jan 2022
Editorial: The Role of Sphingolipid Metabolism in the Development of Type 2 Diabetes and Obesity
doi 10.3389/fendo.2021.835751
- 1,861 views
- 1 citation
- Frontiers in Endocrinology
- Diabetes: Molecular Mechanisms
- Research Topics
- The Role of Sphingolipid Metabolism in the Development of Type 2 Diabetes and Obesity
The Role of Sphingolipid Metabolism in the Development of Type 2 Diabetes and Obesity
16k
Total downloads
44k
Total views and downloads
Articles
REVIEW
Published on 27 Jul 2021
Circulating Ceramides- Are Origins Important for Sphingolipid Biomarkers and Treatments?
doi 10.3389/fendo.2021.684448
- 3,876 views
- 22 citations
REVIEW
Published on 21 May 2021
Apolipoprotein M—A Marker or an Active Player in Type II Diabetes?
doi 10.3389/fendo.2021.665393
- 3,026 views
- 18 citations
MINI REVIEW
Published on 13 May 2021
Ceramides and Sphingosino-1-Phosphate in Obesity
doi 10.3389/fendo.2021.635995
- 4,907 views
- 14 citations
REVIEW
Published on 18 Mar 2021
Sphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes
doi 10.3389/fendo.2021.635175
- 9,408 views
- 69 citations
REVIEW
Published on 09 Feb 2021
Role of Sphingosine Kinase in Type 2 Diabetes Mellitus
doi 10.3389/fendo.2020.627076
- 4,342 views
- 25 citations
MINI REVIEW
Published on 28 Jan 2021
Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease
doi 10.3389/fendo.2020.622692
- 6,427 views
- 29 citations
